Employers start sending workers shopping for health coverage
The new approach started with coverage plans for this year. More workers will likely see them offered this fall during their company’s annual sign-up window for 2021 coverage.
To refine your search through our archives use our Advanced Search
The new approach started with coverage plans for this year. More workers will likely see them offered this fall during their company’s annual sign-up window for 2021 coverage.
The sports bar and restaurant discontinued dine-in service on Oct. 30 because of the rise in COVID-19 cases. It announced Sunday that it had decided to close “until further notice.”
Indiana on Monday issued its weekly COVID-19 data for schools. The state said more than 1,755 schools have reported one or more cases, 220 schools have reported zero cases and 391 schools have provided no data.
A formal withdrawal of project plans was filed Friday, Nov. 20 with the city of Indianapolis, although no reason was offered.
Fast-growing software and consulting company enVista LLC announced Friday that plans to pump millions of dollars into developing and improving supply-chain technology products and services to boost growth.
AstraZeneca is the third major drug company to report late-stage results for a potential COVID-19 vaccine as the world anxiously waits for scientific breakthroughs that will bring an end to a pandemic.
The Indianapolis Colts spent at least $6.3 million to acquire the lots, most of which are vacant and have been used for game parking by third-party vendors since Lucas Oil Stadium opened in 2008.
Host Mason King talks with IBJ reporter Mickey Shuey, who has been covering the story, as well as Mark Ganis, co-founder of Chicago-based Sportscorp. Ltd., and Larry DeGaris, a University of Indianapolis professor and sports marketing consultant, about a proposal to have the city host all of the NCAA tournament games.
The acceleration of coronavirus cases is causing an existential crisis for America’s retailers and spooking their customers just as the critically important holiday shopping season nears.
Promising news about a coronavirus vaccine has small business owners feeling more upbeat. They also realize many hurdles remain as the pandemic shows no signs of abating heading into the winter.
More than 2 million people were screened at U.S. airports on Friday and Saturday, according to the Transportation Security Administration. Friday was only the second time since mid-March that daily airport screenings topped 1 million.
The Indiana State Department of Health on Sunday reported 6,255 new COVID-19 cases, the 12th straight day that the state has reported more than 5,000 new cases.
It is the second drug of this type—called a monoclonal antibody—to be cleared for COVID-19. The FDA authorized Eli Lilly and Co.’s drug on Nov. 9.
The state on Saturday reported 40 new COVID-19 deaths, raising the cumulative total during the pandemic to 4,992.
While an effective vaccine is expected to be widely distributed in 2021, surging U.S. infections are causing renewed angst as government officials re-impose the kind of restrictions that squelched the economy and roiled markets earlier this year.
The Governor’s Office said the couple will continue their 14-day quarantine and can resume a normal schedule with vigilance about masking and social distancing on Dec. 1.
The pandemic has reshaped the most important shopping season of the year, forcing retailers to rethink inventory, store layouts and when, even how, they offer their deepest discounts.
U.S. Treasury Secretary Steven Mnuchin said a decision to end several emergency loan programs being run by the Federal Reserve was based on the fact that the programs were not being heavily utilized.
In a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal challenges from the pharmaceutical industry or whether the incoming Biden administration will accept, amend or try to roll them back entirely.
The not-for-profit launched in 2013 as a way to bridge the gap between research universities and industry in life sciences. But its report card so far is decidedly mixed, and it just hired its third CEO.